Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Food and Drug Administration (FDA)

FY 2015 Appropriations Update:

President Obama March 4 released his fiscal year (FY) 2015 budget, which calls for $3.9 trillion in spending.  The budget adheres to the FY 2015 discretionary (appropriated) spending levels agreed to in the Bipartisan Budget Act (P.L. 113-67), which provide less than a $1 billion increase for non-defense programs. Overall, the administration proposes $71.8 billion for discretionary programs under the Department of Health and Human Services (HHS), a decrease of $206 million (0.3 percent) from FY 2014.

The president requests $2.584 billion in base budget authority for FDA, a $23 million (0.9 percent) increase over the FY 2014 level. In addition, the FDA budget is supplemented by industry user fees, proposed to generate $2.161 billion in FY 2015. This addition brings the total request to $4.745 billion, a $358 million (8.2 percent) increase over the FY 2014 level.

FDA Transparency Initiative

The FDA recently released a report entitled “Food and Drug Administration Transparency Initiative: Exploratory Program to Increase Access to the Agency's Compliance and Enforcement Data.” The report, which was published Feb. 1, is part of the FDA’s Transparency Initiative, intended to enhance the public’s understanding about FDA activities and open avenues of communication by increasing the accessibility of its compliance and enforcement data in a web-based format.

The report lists eight initiatives recommended by the Transparency Task Force that the agency will explore, including: improving data quality; facilitating timely data disclosure; facilitating easier reporting; and offering compliance tools focused on error reporting. The FDA Commissioner adopted all eight proposals and the agency committed to examining additional measures to help prevent misinterpretation or misuse of the compliance and enforcement data that it publically discloses.

Contact

Alexandra Khalife
Legislative Analyst
Telephone: 202-828-0418
Email: akhalife@aamc.org